Multiple superficial injuries of ankle and foot

ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — S90.7 Cause of death: ICD-10 — S90.7 2 out of 7 registries used, show all original rules.	55
4. Check minimum number of events None	55
5. Include endpoints None	55
6. Filter based on genotype QC (FinnGen only)	50

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_ANKLE_FOOT

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S90
Name in latin: Laesiones superficiales multae tarsi/pedis

NAME	ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT
CONTROL_EXCLUDE	ST19_INJURI_ANKLE_FOOT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	S907
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	S907
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Multiple superficial injuries of ankle and foot based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	50	32	18
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	45.36	46.01	44.21

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
51: Matched controls
510

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S90.7

ICD-10 Finland

Multiple superficial injuries of ankle and foot

+∞

73.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

5.5

8.2

S93.4

ICD-10 Finland

Sprain and strain of ankle

7.4

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2.50

2.23

1.4

1.3

30.75

29.07

iu/ml

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.85

1.90

1.7

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

4.49

1.87

1.2

2.7

103.20

219.17

ug/l

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

4.49

1.87

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.97

1.81

1.9

2.7

0.20

0.23

g/l

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

3.63

1.80

1.2

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.63

1.80

2.0

2.2

—

(3022313) Gas panel - Capillary blood

4.14

1.76

5.8

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

127

2.11

1.72

3.4

3.5

78.07

25.12

ng/l

0.35

(40758558) Short blood count panel - Blood

132

2.00

1.53

6.4

5.9

—

(4024509) Urine culture

2.95

1.48

2.5

1.9

—

(3026008) Bacteria identified in Urine by Culture

100

2.05

1.47

2.8

3.0

—

(3032080) INR in Blood by Coagulation assay

160

1.94

1.47

4.2

9.7

1.02

1.08

inr

1.38

134

(3004716) Salmonella sp identified in Stool by Organism specific culture

0.00

1.41

0.0

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

0.00

1.40

0.0

2.7

—

12340.61

—

(42870588) Differential panel, method unspecified - Blood

142

1.81

1.18

7.6

7.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.66

1.18

1.6

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2.66

1.18

1.6

1.5

6.48

6.44

u/l

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.53

1.11

1.2

7.6

19.46

16.67

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2.02

1.08

1.9

3.5

0.83

0.81

mmol/l

0.16

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.89

1.04

1.5

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

158

1.69

0.97

2.0

1.9

100.00

95.40

pmol/l

0.20

(3000991) Gas panel - Venous blood

2.38

0.97

5.3

6.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

121

0.51

0.93

3.7

4.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.13

0.90

1.0

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.92

0.89

2.9

6.2

101.88

105.00

mmol/l

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1.79

0.89

3.5

2.6

1093.23

517.33

ng/l

0.43

(3033658) Prothrombin time (PT) actual/Normal

1.74

0.86

3.9

5.2

90.43

98.74

0.56

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

354

1.81

0.85

4.0

3.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.83

0.85

1.5

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.76

0.85

2.3

1.6

—

(3019225) pH of Specimen

1.99

0.85

10.3

3.6

7.39

7.28

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.99

0.85

1.5

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.86

0.83

2.6

2.1

—

(36304419) Bacteria [Presence] in Urine

110

1.66

0.81

3.0

2.5

—

estimate

—

(3031040) Bacteria [#/volume] in Urine by Automated count

262

1.59

0.79

5.3

4.0

—

44.14

—

(3030467) Casts [#/volume] in Urine by Automated count

102

1.67

0.79

3.4

2.6

0.03

0.28

e6/l

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2.30

0.78

4.0

1.9

2.60

0.80

mmol/l

—

(3022096) Basophils/Leukocytes in Blood

213

1.57

0.78

8.1

6.8

0.81

0.74

0.29

203

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.87

0.75

1.7

2.2

—

(1761868) Lipid panel - Serum or Plasma

213

0.64

0.71

1.6

2.5

—

(3018010) Neutrophils/Leukocytes in Blood

219

1.49

0.66

8.2

6.6

57.35

56.33

0.19

213

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.52

0.63

1.2

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.61

0.0

2.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.61

0.0

1.5

—

(3021589) Normoblasts [#/volume] in Blood

193

1.46

0.59

8.7

11.8

0.00

e9/l

0.50

156

(3006504) Eosinophils/Leukocytes in Blood

214

1.44

0.56

8.3

6.8

2.29

2.89

1.26

205

(3002030) Lymphocytes/Leukocytes in Blood

225

1.43

0.54

8.0

6.7

28.68

29.47

0.17

217

(3000494) Fungus identified in Specimen by Culture

1.64

0.51

1.3

—

(3019069) Monocytes/Leukocytes in Blood

217

1.40

0.51

8.3

6.8

8.75

8.39

0.24

208

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

192

0.69

0.51

2.1

1.8

1.61

1.44

mmol/l

0.28

168

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

212

0.70

0.49

5.1

7.2

10.24

10.80

umol/l

0.09

204

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

189

1.40

0.48

2.8

2.9

—

estimate

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.4

—

46.27

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.40

0.0

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1.43

0.39

3.8

6.3

140.40

124.58

g/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

137

1.36

0.39

2.1

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

344

0.75

0.38

4.0

3.1

62.87

36.36

u/l

1.14

332

(3018095) Leukocytes [#/volume] in Urine

158

1.32

0.35

4.4

3.4

156.92

51.70

e6/l

0.56

105

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

0.68

0.35

4.4

4.6

2.05

1.78

ug/l

—

(3013512) EKG study

111

1.36

0.35

3.6

2.8

—

(40768804) Tissue Pathology biopsy report

168

1.31

0.34

2.3

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.34

0.34

3.2

1.7

—

(3042936) Bacteria identified in Isolate by Culture

1.34

0.32

2.7

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.34

0.29

3.6

3.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

115

1.30

0.27

2.2

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

435

0.80

0.27

4.5

4.2

4.60

4.73

mmol/l

0.41

411

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

434

0.82

0.26

4.5

4.1

1.40

1.46

mmol/l

0.50

410

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

426

1.48

0.26

20.6

13.5

16.68

19.99

mg/l

0.48

335

(3011288) Drugs identified in Urine by Screen method Nominal

1.35

0.24

1.8

2.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

406

1.38

0.24

3.6

3.5

1.34

1.22

mmol/l

0.50

382

(40761536) Microorganisms panel - Urine sediment

1.31

0.23

2.8

2.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.31

0.22

2.4

2.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

50.50

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.21

0.0

1.8

—

7.21

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.21

0.0

1.4

—

8.08

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3035933) Granulocytes/Leukocytes in Blood

0.00

0.20

0.0

1.9

—

60.21

—

(40768793) Breast Pathology biopsy report

0.00

0.20

0.0

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.20

0.0

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.20

0.0

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.20

0.0

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

111

1.23

0.18

2.3

2.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

435

1.29

0.17

20.9

12.9

139.49

139.90

mmol/l

0.61

427

(3003694) ABO and Rh group [Type] in Blood

141

1.20

0.16

1.9

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

107

0.81

0.14

3.1

2.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

133

1.18

0.14

3.5

2.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

183

1.15

0.13

2.0

3.0

0.00

0.02

estimate

—

(3023368) Bacteria identified in Blood by Culture

1.19

0.10

4.7

4.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.15

0.10

3.2

1.8

—

(3022145) Colonoscopy Study observation

1.10

0.10

1.0

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.10

0.10

1.8

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

463

0.93

0.10

20.7

15.4

81.09

73.32

umol/l

0.30

457

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.05

0.09

7.4

4.0

29.40

30.30

—

(3000492) Spirometry study

1.13

0.09

1.2

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

117

1.15

0.09

3.0

2.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

436

1.27

0.08

21.2

13.0

3.99

3.94

mmol/l

0.57

427

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1.06

0.08

2.6

1.9

1.39

1.36

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

130

1.11

0.05

1.5

1.3

0.88

1.41

u/ml

—

(3021601) Nitrite [Presence] in Urine by Test strip

231

1.07

0.03

2.8

3.4

0.00

estimate

—

(3041096) Erythrocytes [Presence] in Urine by Automated

148

0.93

0.03

1.9

2.7

0.00

estimate

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

344

1.06

0.00

6.0

4.4

14.10

14.59

pmol/l

0.61

322

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

411

0.99

0.00

7.2

5.3

1.62

1.74

mu/l

0.38

390

(3015377) Calcium [Moles/volume] in Serum or Plasma

131

0.99

0.00

3.1

3.2

2.41

2.35

mmol/l

0.67

120

(3019832) Treponema pallidum Ab [Presence] in Serum

1.07

0.00

1.8

1.7

—

(3015736) pH of Urine

185

0.96

0.00

2.9

3.0

6.15

6.13

—

104

(3035350) Ketones [Presence] in Urine by Test strip

235

1.04

0.00

2.8

3.4

0.00

estimate

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

144

0.96

0.00

3.1

2.4

—

(3009261) Glucose [Presence] in Urine by Test strip

236

1.03

0.00

2.9

3.5

0.00

estimate

—

(44806118) Parainfluenza type 4 nucleic acid detection

0.00

-0.00

0.0

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.0

—

33.50

—

(1616796) Gas panel - Central venous blood

0.00

-0.00

0.0

4.4

—

(21494815) CD4 cells/Lymphocytes in Specimen

0.00

-0.00

0.0

1.4

—

39.90

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

178.16

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3021901) Oxygen saturation in Capillary blood

0.00

-0.00

0.0

2.6

—

91.29

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

-0.00

0.0

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

1.0

—

90.58

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.6

—

157.14

—

(3037756) Immunofixation for Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

2.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

-0.00

0.0

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

2.48

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3002256) Pathology report gross observation

0.90

-0.00

1.4

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3039000) Anion gap in Blood by calculation

0.00

-0.00

0.0

5.8

—

10.67

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

5.2

—

3.07

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

3.3

—

4.60

—

(44790047) Parainfluenza type 1 nucleic acid detection

0.00

-0.00

0.0

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

-0.00

0.0

1.2

—

(36660697) Celiac disease serology panel - Serum

0.94

-0.00

1.4

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.3

—

1.00

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.0

—

20.46

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

8.86

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.5

—

(40768806) Pleura Pathology biopsy report

0.00

-0.00

0.0

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

6.93

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.7

—

(3035715) Granulocytes [#/volume] in Blood

0.00

-0.00

0.0

2.2

—

4.74

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.2

—

271.00

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

-0.00

0.0

3.3

—

7.95

—

(3018572) Chloride [Moles/volume] in Blood

0.00

-0.00

0.0

5.8

—

106.11

—

(4195642) Thrombophilia screening test

0.00

-0.00

0.0

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(44790049) Parainfluenza type 3 nucleic acid detection

0.00

-0.00

0.0

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

67.00

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

-0.00

0.0

3.3

—

5.08

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.6

—

5.53

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

-0.00

0.0

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.4

—

35.60

—

(4211845) Urine protein measurement

0.00

-0.00

0.0

1.4

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

3.3

—

10.65

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT – Multiple superficial injuries of ankle and foot

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Multiple superficial injuries of ankle and foot

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Multiple superficial injuries of ankle and foot (ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints